WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NKTR

Based on 6 analysts offering 12 month price targets for Nektar Therapeutics

Min Forecast
$80.00+25.27%
Avg Forecast
$156.00+144.28%
Max Forecast
$192.00+200.66%

Should I buy or sell NKTR stock?

Based on 6 analysts offering ratings for Nektar Therapeutics.

Strong Buy
Strong Buy
4 analysts 66.67%
Buy
1 analysts 16.67%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NKTR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NKTR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NKTR stock forecasts and price targets.

NKTR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-11
lockedlocked$00.00+00.00%2026-05-08Find Out Why
lockedlocked$00.00+00.00%2026-04-21Find Out Why
lockedlocked$00.00+00.00%2026-04-20
lockedlocked$00.00+00.00%2026-04-20
B. Riley Securities
Top 4%
97
Strong BuyReiterates$150.00+134.89%2026-02-23Find out why

1 of 1

Forecast return on equity

Is NKTR forecast to generate an efficient return?

Company
-71.35%
Industry
92.87%
Market
169.3%
NKTR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NKTR forecast to generate an efficient return on assets?

Company
-53.86%
Industry
27.75%
NKTR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NKTR earnings per share forecast

What is NKTR's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
-$9.24
Avg 2 year Forecast
-$11.30
Avg 3 year Forecast
-$11.63

NKTR revenue forecast

What is NKTR's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$41.9M-24.77%
Avg 2 year Forecast
$37.6M-32.33%
Avg 3 year Forecast
$47.5M-14.61%
NKTR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NKTR revenue growth forecast

How is NKTR forecast to perform vs Biotechnology companies and vs the US market?

Company
-6.83%
Industry
35.45%
Market
14.02%
NKTR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NKTR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NKTR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NKTR$63.86$156.00+144.28%Strong Buy
BCRX$8.57$22.00+156.71%Buy
RARE$22.85$54.80+139.82%Strong Buy
ELVN$37.51$53.33+42.18%Strong Buy
RXRX$3.79$8.10+113.72%Buy
View Top Biotech Stocks

Nektar Therapeutics Stock Forecast FAQ

Is Nektar Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: NKTR) stock is to Strong Buy NKTR stock.

Out of 6 analysts, 4 (66.67%) are recommending NKTR as a Strong Buy, 1 (16.67%) are recommending NKTR as a Buy, 1 (16.67%) are recommending NKTR as a Hold, 0 (0%) are recommending NKTR as a Sell, and 0 (0%) are recommending NKTR as a Strong Sell.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.

What is NKTR's earnings growth forecast for 2026-2028?

(NASDAQ: NKTR) Nektar Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.26%.

Nektar Therapeutics's earnings in 2026 is -$158,098,000.On average, 12 Wall Street analysts forecast NKTR's earnings for 2026 to be -$312,267,401, with the lowest NKTR earnings forecast at -$364,875,631, and the highest NKTR earnings forecast at -$270,322,042. On average, 12 Wall Street analysts forecast NKTR's earnings for 2027 to be -$381,633,503, with the lowest NKTR earnings forecast at -$464,966,751, and the highest NKTR earnings forecast at -$244,212,197.

In 2028, NKTR is forecast to generate -$392,857,223 in earnings, with the lowest earnings forecast at -$474,139,659 and the highest earnings forecast at -$260,105,146.

What is NKTR's revenue growth forecast for 2026-2028?

(NASDAQ: NKTR) Nektar Therapeutics's forecast annual revenue growth rate of -6.83% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.02%.

Nektar Therapeutics's revenue in 2026 is $55,633,000.On average, 12 Wall Street analysts forecast NKTR's revenue for 2026 to be $1,414,080,583, with the lowest NKTR revenue forecast at $794,647,473, and the highest NKTR revenue forecast at $1,588,044,862. On average, 12 Wall Street analysts forecast NKTR's revenue for 2027 to be $1,272,010,319, with the lowest NKTR revenue forecast at $268,193,522, and the highest NKTR revenue forecast at $1,619,803,732.

In 2028, NKTR is forecast to generate $1,605,039,236 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $4,244,539,200.

What is NKTR's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: NKTR) forecast ROA is -53.86%, which is lower than the forecast US Biotechnology industry average of 27.75%.

What is NKTR's Price Target?

According to 6 Wall Street analysts that have issued a 1 year NKTR price target, the average NKTR price target is $156.00, with the highest NKTR stock price forecast at $192.00 and the lowest NKTR stock price forecast at $80.00.

On average, Wall Street analysts predict that Nektar Therapeutics's share price could reach $156.00 by May 11, 2027. The average Nektar Therapeutics stock price prediction forecasts a potential upside of 144.28% from the current NKTR share price of $63.86.

What is NKTR's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: NKTR) Nektar Therapeutics's current Earnings Per Share (EPS) is -$8.23. On average, analysts forecast that NKTR's EPS will be -$9.24 for 2026, with the lowest EPS forecast at -$10.80, and the highest EPS forecast at -$8.00. On average, analysts forecast that NKTR's EPS will be -$11.30 for 2027, with the lowest EPS forecast at -$13.76, and the highest EPS forecast at -$7.23. In 2028, NKTR's EPS is forecast to hit -$11.63 (min: -$14.03, max: -$7.70).

What is NKTR's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: NKTR) forecast ROE is -71.35%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.